Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 48,695 | 30,290 | 12,276 | N/A |
| Depreciation Amortization | N/A | 110,156 | 71,668 | 34,090 | N/A |
| Accounts receivable | 2,074,024 | 32,650 | 32,067 | 19,991 | 1,956,084 |
| Accounts payable and accrued liabilities | -1,808,687 | -4,645 | -32,564 | -47,666 | -1,730,062 |
| Other Working Capital | 218,736 | -48,672 | -39,644 | -57,337 | 173,514 |
| Other Operating Activity | -268,007 | -16,870 | 7,890 | 31,198 | -213,326 |
| Operating Cash Flow | $216,066 | $121,314 | $69,707 | $-7,448 | $186,210 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -58,542 | -56,021 | -42,001 | -15,929 | -49,220 |
| PPE Investments | -141,038 | -95,945 | -56,844 | -25,295 | -111,921 |
| Net Acquisitions | -14,165 | -11,785 | -11,477 | -9,634 | -4,356 |
| Purchase Of Investment | N/A | -6 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -135 | N/A | -6 | N/A | -1,372 |
| Other Investing Activity | -135 | 0 | -6 | 0 | -1,372 |
| Investing Cash Flow | $-213,880 | $-163,757 | $-110,328 | $-50,858 | $-166,869 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -303 | N/A | N/A | N/A | -282 |
| Debt Repayment | N/A | -231 | -156 | -77 | N/A |
| Common Stock Issued | 11,280 | 8,828 | 6,875 | 3,768 | 8,236 |
| Other Financing Activity | -1,957 | -2,406 | -3,425 | -3,433 | 627 |
| Financing Cash Flow | $9,020 | $6,191 | $3,294 | $258 | $8,581 |
| Exchange Rate Effect | -12,858 | -3,358 | -1,571 | 4,114 | 16,376 |
| Beginning Cash Position | 458,823 | 457,549 | 457,549 | 457,549 | 413,251 |
| End Cash Position | 457,171 | 417,939 | 418,651 | 403,615 | 457,549 |
| Net Cash Flow | $-1,652 | $-39,610 | $-38,898 | $-53,934 | $44,298 |
| Free Cash Flow | |||||
| Operating Cash Flow | 216,066 | 121,314 | 69,707 | -7,448 | 186,210 |
| Capital Expenditure | -141,436 | -96,323 | -56,865 | -25,296 | -112,000 |
| Free Cash Flow | 74,630 | 24,991 | 12,842 | -32,744 | 74,210 |